Towards Non-Invasive Bedside Monitoring of Cerebral Blood Flow and Oxygen Metabolism in Brain-Injured Patients with Near-Infrared Spectroscopy by Mamadou Diop et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
14 
Towards Non-Invasive Bedside Monitoring  
of Cerebral Blood Flow and Oxygen  
Metabolism in Brain-Injured Patients  
with Near-Infrared Spectroscopy 
Mamadou Diop, Jonathan T. Elliott, Ting-Yim Lee and Keith St. Lawrence 
Imaging Division, Lawson Health Research Institute 
London, Ontario  
Canada 
1. Introduction 
Monitoring the injured brain to detect and treat harmful events that can cause secondary 
injury during the acute recovery period is a central part of neurointensive care. The most 
basic monitoring tool is the neurological examination, such as the Glasgow Coma Score; 
however, a large component of this scale involves verbal communication and brain-
injured patents are often comatose, mechanically ventilated or sedated. As well, 
symptoms of neurological deterioration detected by examination often occur at late stages 
of brain injury. Since the brain is extremely vulnerable to ischemia, a more direct indicator 
of potential brain injury is detecting impaired cerebral blood flow (CBF). Multiple factors 
following brain injury can cause ischemia, including systemic hypotension, cerebral 
hemorrhage, and edema – all of which independently worsen survival (Helmy et al., 
2007). This focus has lead to the recognition that continuous monitoring of CBF in patients 
with, or at risk of, brain injury could improve outcome by providing the ability to detect 
and prevent cerebral ischemia. 
Imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography 
(CT), are critical to the management of brain-injured patients as they provide detailed 
structural and functional information of the brain when patients are admitted to an 
emergency department (Gallagher et al., 2007). CT is the modality of choice because it is 
widely available and examination times are relatively short. Furthermore, techniques for 
measuring CBF have been developed on these imaging modalities (Wintermark et al., 2005) 
and subsequently used to identify CBF abnormalities following brain injury (DeWitt & 
Prough, 2003; Gowda et al., 2006; Soustiel et al., 2008). Despite these promising advances, 
conventional imaging modalities suffer from serious disadvantages regarding cerebral 
monitoring. First, they require transferring patients to imaging facilities which represents a 
significant risk factor when dealing with critically ill patients. Second, they only provide a 
single time-point measurement and, therefore, suffer from the possibility of missing flow 
abnormalities that occur at different times during intensive care. Clearly, effective cerebral 
monitoring requires bedside techniques. 
www.intechopen.com
 
Brain Injury – Pathogenesis, Monitoring, Recovery and Management 
 
280 
Since CBF is driven in part by the cerebral perfusion pressure (CPP) which depends on 
intracranial pressure (ICP), using these pressures as surrogate markers of CBF is becoming 
an integral part of critical care practice. Intracranial pressure is typically measured using 
either a ventricular catheter or an intraparenchymal probe, and CPP is determined by the 
difference between mean arterial pressure (MAP) and ICP. Although there have been no 
large randomized trials comparing target thresholds, it is generally recommended that the 
ICP threshold above which treatment should be initiated is between 20-25 mm Hg (Bratton 
et al., 2007b). Similarly, CPP should be maintained above 60 mm Hg to ensure adequate CBF 
(Bratton et al., 2007a). However, the thresholds for ICP and CPP remain a source of 
contention. Increasing CPP (70-90 mm Hg) was found to reduce ischemia (Coles et al., 2004), 
but comes at the cost of increased incidence of extracranial complications and possibly 
contributes to vasogenic edema (Robertson et al., 1999). The Lund protocol advises a lower 
limit of 50 mm Hg to prevent complications while avoiding extremely low CBF (Asgeirsson 
et al., 1994). It has even been suggested that CPP/ICP therapy only increases therapy 
intensity without improving outcome (Cremer, 2008). Strictly adhering to targets can 
therefore give clinicians a false sense of security. A method of measuring CBF at the bedside 
would remove this ambiguity since the occurrence of ischemia due to inadequate CPP or 
hyperemia due to excessive CPP therapy would be readily apparent. 
The most widely used beside technique for monitoring CBF is transcranial Doppler (TCD). 
This non-invasive technique derives blood flow velocity from the Doppler shift caused by 
moving red blood cells in a cerebral artery. Provided the angle of insonation and the 
diameter of the interrogated vessel remain constant, changes in TCD measurements reflect 
CBF changes (Valdueza et al., 1997). However, the accuracy of TCD is operator dependent 
due to problems of probe fixation, the TCD signal is not found in 10-30% of patients, and the 
technique cannot monitor blood flow in the microvasculature, which can be quite different 
from flow in the major arteries (Wright, 2007). Invasive techniques for monitoring CBF that 
require inserting probes directly into brain tissue include laser Doppler (LDF) and thermal 
diffusion flowmetry (TDF) (Bolognese et al., 1993; Sioutos et al., 1995). These techniques 
have been used to detect ischemia in brain-injured patients and TDF was shown to be more 
sensitive than TCD to assessing vasospasm, demonstrating the value of assessing CBF 
directly (Kirkpatrick et al., 1994; Vajkoczy et al., 2001). Besides being invasive, the major 
limitation with LDF and TDF is that they can only monitor the vascular territory where the 
probes are placed. Wider applicability of CBF monitoring requires non-invasive techniques 
that can assess CBF in multiple brain regions. 
A promising alterative to current invasive monitoring techniques is near-infrared spectroscopy 
(NIRS). Due to the relative transparency of biological tissue to near-infrared (NIR) light, the 
brain can be interrogated non-invasively by probes placed on the scalp (Jobsis, 1977). Not only 
is NIRS non-invasive and safe, due to the use of non-ionizing radiation, the major tissue 
endogenous chromophores – water, oxy- and deoxy-hemoglobin (HbO2 and Hb), cytochrome 
c oxidase, and lipids – have unique absorption properties in this wavelength range. The 
challenge to quantifying tissue chromophores concentrations with NIRS is the need to account 
for the strong light scattering, which dominates over light absorption. To meet this challenge, 
techniques that can take into account the effects of scattering have been developed and NIRS is 
now widely used to continuously monitor HbO2 and Hb, and derive cerebral blood 
oxygenation. The most reported NIRS parameter is the ratio of HbO2 to total haemoglobin (i.e., 
HbO2 + Hb), which reflects cerebral blood oxygen saturation and is commonly referred to as 
the tissue oxygenation index (TOI). The TOI has been proposed for detecting ischemia and 
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assessing autoregulation by comparison to MAP (Al-Rawi & Kirkpatrick, 2006; Brady et al., 
2008). The difficulties with using TOI as a surrogate of CBF are that blood oxygenation is 
influenced by multiple factors (CBF, cerebral metabolism, arterial saturation and hematocrit) 
and the “normal range” has yet to be defined. Reported TOI values have ranged from 60 to 
85%, and this variation is as great as the change attributed to ischemia (Al-Rawi & Kirkpatrick, 
2006; Thavasothy et al., 2002; Yoshitani et al., 2002). 
NIRS techniques that can directly measure CBF have been developed. The first method proposed 
was based on the Fick principle and used a rapid change in arterial oxygen concentration as a 
blood flow tracer (Edwards et al., 1988). Improved sensitivity was achieved using indocyanine 
green (ICG) due to its strong light-absorbing properties (Patel et al., 1998). This FDA-approved 
dye has been in clinical use for over 30 years and has a high safety record; a study involving 
more than 3000 human subjects, showed that intravenous injection of ICG resulted in 
significant allergic reaction in only one subject (Hope-Ross et al., 1994). Absolute CBF, rather 
than a relative measure, was obtained with the ICG approach using a dye densitometer, to 
measure the arterial blood ICG concentration, a NIRS method capable of quantifying the tissue 
ICG concentration and a deconvolution method (Brown et al., 2002; Springett et al., 2001). 
Because of the inherent sensitivity of NIRS to blood oxygenation, CMRO2 can also be 
measured by combining NIRS measurements of CBF and oxygenation. In addition, CMRO2 
has been shown to be a better marker of injury severity in hypoxia-ischemia than CBF alone 
(Tichauer et al., 2006a). In this chapter we will show that NIRS can be used to measure cerebral 
blood flow and oxygen metabolism, and to detect general and focal brain injuries. 
2. Theory 
2.1 Cerebral blood flow model 
The hemodynamics of an organ can be quantified by tracking the passage of a contrast agent 
through the vascular bed, an approach that has been adapted to imaging modalities including 
MRI and CT, and to NIRS. With this method, the amount of contrast agent in the organ at a 
given time t (Q(t)) is related to the difference between its arterial (Ca(t)) and venous 
concentrations (Cv(t)), and to blood flow (F) via the Fick Principle (Meier & Zierler, 1954): 
 
( )
( ) ( ).a v
dQ t
FC t FC t
dt
    (1) 
If Q(t), Ca(t) and Cv(t) could be measured non-invasively, then the calculation of flood flow 
would be a simple mathematical operation but that is not the case since Cv(t) cannot be 
measured noninvasively. However, the venous concentration of contrast agent can be 
expressed in term of Ca(t) as (Lee, 2002): 
 
( ) ( ) ( ),v aC t C t h t    (2) 
where * is the convolution operator and h(t) is the impulse response function of the organ 
(i.e., the distribution of transit times) and represents the venous concentration of contrast 
agent if the arterial input was a Dirac-delta function. From Eq. (1) and (2) it can be shown 
that Q(t) can be expressed as (Lee, 2002): 
 
( ) ( ) ( )aQ t C t F R t   .                  (3) 
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Equation (3) shows that CBF can be determined by measuring Q(t) and Ca(t), and applying a 
deconvolution technique to extract F·R(t). The initial height of the function F·R(t) is CBF, as 
by definition R(0) = 1, and the area under the curve is the cerebral blood volume (CBV) 
(Brown et al., 2002). It is clear from Eq. (3) that determining CBF requires the quantification 
of the tracer concentration in the brain. Fig. 1 shows an example of Q(t) and Ca(t) measured 
on a piglet and the retrieved F·R(t). 
 
 
Fig. 1. (A) An example of tissue and arterial ICG concentration curves measured with a 
NIRS apparatus and a dye densitometer respectively.  The curves were measured 
simultaneously over a period of 50 seconds after injection of an ICG bolus. The peak arterial 
concentration is approximately 20 times greater than that of tissue. This is because blood 
volume in tissue is approximately 5 % of the total tissue volume. (B) Cerebral blood flow 
scaled impulse residue function, F.R(t), retrieved from the deconvolution of the curves in 
(A). Height of initial plateau yields CBF (50 ml/min/100g) and area under the curve is CBV. 
2.2 Measuring the cerebral metabolic rate of oxygen 
The NIRS CBF measurements can be used to determine CMRO2 by applying the Fick 
Principle (Tichauer et al., 2006b): 
 2 2
( )CMRO F AVDO  ,  (4) 
where AVDO2 is the arterial-venous difference of oxygen, or the difference between the 
oxygen concentration of the arterial system feeding the tissue of interest and the oxygen 
concentration of the venous system draining the tissue. Assuming that the oxygen content of 
arterial blood is the same throughout the body (Brown et al., 2003), the arterial O2 
concentration can be obtained from hemoximeter analysis of arterial blood samples from a 
periphery artery or non-invasively from a pulse oximeter. The venous O2 concentration is 
more difficult to determine non-invasively. However, considering that the Hb measured in 
the brain is due solely to O2 dissociation from HbO2, the NIRS measurements of tissue Hb 
concentration can be used as an indirect measure of the venous O2 concentration. With this 
approach, it is necessary to account for the fact that the tissue Hb concentration is a 
weighted average of the three blood compartments: arterial, capillary and venous. The 
relative distribution of arterial, capillary, and venous compartments in the total CBV is 
generally accepted to be approximately 20%, 10%, and 70% respectively (Phelps et al., 1979). 
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Assuming that the capillary concentration of Hb is the average of arterial and venous 
concentrations, the venous concentration of Hb can be expressed as: 
      4 1
3 3
T
V a
Hb
Hb Hb
CBV     , (5) 
where  VHb ,  THb , and   aHb  are the venous, tissue, and arterial concentrations of Hb, 
respectively. The tissue Hb concentration,  THb , is measured by NIRS and   aHb  can be 
measured by either hemoximeter analysis of an arterial blood sample or pulse oximetry. The 
NIRS measurement of  THb  is normalized by the dilution factor, CBV  , to determine the 
concentration of Hb in just the blood compartment of the tissue region of interest. The 
density of brain tissue,  , is 1.05 g/ml and is used to convert the CBV from volume of 
blood per mass of tissue to volume of blood per volume of tissue. Finally, with knowledge 
of the total hemoglobin (tHb = Hb + HbO2) measured from a blood sample, the venous O2 
concentration can be determined as follows (Brown et al., 2003): 
 2 2
VenousO Concentration ([ ] [ ] ) 1.39ml O /gHbvtHb Hb   .                        (6) 
3. Measurement of Q(t) and Ca(t) 
3.1 Measurement of tissue chromophores concentration  
Fig. 2 shows a picture of the cart housing the broadband continuous-wave NIRS instrument. 
The main components of the apparatus are the light source, the fiber optic cables (optodes), 
and the spectrometer. The light source is a power-stabilized halogen light bulb and the 
spectrometer consists of a holographic grating and a cooled CCD camera. During 
measurements, the two optodes are placed 3.0 cm apart on the skull of the subject. One 
optode is used to guide the light from the source to the head and the other collects light re-
emitted from the head and transmits it to the holographic grating of the spectrometer, where 
it is dispersed across the cooled CCD chip (cooled to 70°C to reduce electronic dark noise) to 
generate an attenuation spectrum every 200 ms. 
Measured spectra were analyzed on the basis of the principle that when NIR light enters 
tissue, it is multiply scattered and partially absorbed by endogenous tissue chromophores, 
such as water, HbO2, Hb, cytochrome c oxidase, and lipids. Since scattering causes the total 
pathlength traveled by the NIR light from the emission optode to detection probe to be 
larger than the physical distance between the two optodes, a simple approach is to take into 
account the increase in pathlength using the differential pathlength factor (DPF), as first 
described by Delpy et al. (Delpy et al., 1988). With accurate knowledge of the DPF, a 
modified version of the Beer-Lambert law can be used to determine absolute changes in the 
concentrations of the NIR absorbers (Cope, 1991): 
 
( ) ( )i i
i
A c DPF L        ,     (7) 
where ( )A   is the change in the attenuation spectra, ic  is the absolute change in 
concentration of the ith NIR absorber, L is the physical distance between the emission and 
detection probes, and ( )i   is the extinction coefficient of the ith NIR absorber as a function 
of wavelength. In particular, Eq. (7) can be used to quantify tissue ICG concentration, 
following a bolus injection of the dye, since there is no ICG in the brain prior to the injection. 
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Furthermore, the second derivative technique described by Matcher et al. (Matcher et al., 
1994) can be applied to the broadband data, in conjunction with the assumption of 85% 
water concentration in the brain in infants and 80% in adults (Matcher & Cooper, 1994), to 
obtain the DPF and absolute concentrations of endogenous absorbers – as opposed to 
absolute changes of concentrations – in real time. 
 
 
Fig. 2. Picture of the potable NIRS apparatus. 
3.2 Arterial ICG concentration measurement 
Arterial ICG concentration can be measured noninvasively on a peripheral artery (e.g., a 
foot in the case of a piglet) using a dye densitometer unit (model DDG-2001 A/K, Nihon 
Kohden, Tokyo, Japan). The probe of the dye densitometer can be held on the skin using a 
spring-loaded clip, much the same as used for a regular pulse oximeter probe.  
4. Validation experiments 
4.1 CBF validation 
Cerebral blood flow and blood volume were altered in a newborn piglet model, by changing 
the partial arterial carbon dioxide tension (PaCO2), and concomitantly measured with 
NIRS and CT perfusion (Brown et al., 2002). Because of the portable nature of the NIRS 
apparatus, both NIRS and CT measurements were acquired with the piglet in the CT 
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scanner. Newborn piglets (less than a week old) were chosen to avoid complications due to 
extracerebral contamination of the NIRS signal that occurs in older subjects, which is 
discussed section 6. As shown in Fig. 3, there is a strong linear correlation between CT and 
NIRS hemodynamic measurements over a wide range. In addition, there is no significant 
statistical difference between CT and NIRS measurements of CBF and CBV, and the 
estimated bias are small relative to the respective mean values in each case. The precision of 
NIRS CBF and CBV measurements - determined using analysis of variance of repeated 
measurements - were 9.71% and 13.05% respectively. These results show that this NIRS 
technique is capable of accurate and reliable bedside measurement of cerebral 
hemodynamics in newborn piglets. 
 
 
 
 
Fig. 3. Comparison of CT and NIRS measurements of cerebral blood flow and blood  
volume. 
There are, however, some challenges facing the clinical application of the technique. 
Although the piglet head mimics that of a neonate in terms of skull composition and 
thickness, the two are significantly different in size and dimension. In this validation study 
an inter-optode distance of 3.0 cm was used and this yields a maximum depth of light 
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penetration of ~1.73 cm (Brown et al., 2002). This inter-optode separation should be 
appropriate for neonatal application since it has been shown that in this population, the 
thickness of the tissue overlying the brain are typically less than 5 mm and do not 
significantly interfere with NIR monitoring of the brain for inter-optode distance of at least 3 
cm (Benaron et al., 1995). A potential inconvenience with this technique is that it requires an 
ICG injection. Although the use of an exogenous blood flow tracer is somewhat less 
appealing than using one of the endogenous NIR absorbers (for example HbO2 or Hb), ICG 
results in a much higher signal-to-noise ratio. 
This study demonstrated the ability of NIRS to accurately measure cerebral hemodynamics 
at the bedside and showed that this technique can monitor and diagnose ischemic injury in 
neonates. In ischemic brain injury, CBF is often low for an extended period of time before 
symptoms of injury are apparent. The ability to detect diminished CBF at an earlier stage 
would significantly aid earlier intervention and greatly reduce mortality and morbidity. It 
has also been suggested that loss of PaCO2 reactivity is associated with poor 
neurodevelopmental outcome and/or hypoxic-ischemic encephalopothy and that the loss of 
PaCO2 reactivity is a candidate for predicting early severe brain damage in preterm infants 
(Blankenberg et al., 1997; Muller et al., 1997). Because the NIRS-CBF technique is capable of 
providing reliable, non-invasive, repeatable measurements it can be used to detect loss of 
PaCO2 reactivity, thereby greatly improving diagnosis. 
4.2 CMRO2 validation 
The cerebral metabolic rate of oxygen measured by the NIRS technique were compared to 
CMRO2 determined from the product of CBF and the cerebral arterial-venous difference in 
oxygen (AVDO2) measured from blood samples (Tichauer et al., 2006b). The experiments 
were conducted in newborn piglets subjected to five cerebral metabolic states created by 
varying the plane of anesthesia. The blood samples were collected from a peripheral artery 
and the superior sagittal sinus. As such, the two CMRO2 measurements were not collected 
from exactly the same brain volumes. However, there should be significant overlap between 
the two sampled volumes since both techniques primarily measure cortical tissue (Scremin 
et al., 1982). In addition, partial volume errors were avoided by using anesthetics to alter 
CMRO2 globally (Schultz, 1978). No statistically significant difference was found, within a 
range of ~ 1.5 to 4.0 mlO2/min/100g, between CMRO2 measurements obtained with the two 
techniques at any anesthetic level. There was also a strong correlation between concomitant 
CMRO2 values obtained from the two techniques (Fig. 3 in Tichauer et al., 2006b). 
Furthermore, repeated measurements obtained while maintaining constant CMRO2 showed 
that the NIRS technique can measure CMRO2 with a precision of 10.7%. All of this shows 
that CMRO2 can be determined accurately by combining NIRS measurements of CBF and 
deoxy-hemoglobin. 
It is evident from Eq. 4 that there are two key parameters that must be determined 
accurately to calculate CMRO2: CBF and AVDO2. Due to the difficulty of measuring these 
parameters, introduced by the high scattering properties of biological tissue, few studies 
have attempted to measure absolute CMRO2 with NIRS. In this validation, the second 
derivative technique was applied to broadband data to account for scattering (Matcher et 
al., 1994) and real-time measurements of the differential pathlength were acquired using 
the known water concentration in brain (Matcher & Cooper, 1994). A consequence of the 
second derivative approach is that the AVDO2 must be calculated solely from the Hb 
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signal as the second derivative of the HbO2 absorption spectrum is relatively featureless 
(Cope, 1991). With this approach, an independent measure of the arterial oxygenation 
must be obtained, which can be determined directly from an arterial blood sample or 
indirectly from the arterial oxygen saturation. It is also necessary to normalize the tissue 
by CBV, which was obtained from the ICG measurements, and to assume a relative 
distribution of in the vasculature. 
Quantitative measures of AVDO2 were calculated under the assumption that the relative 
contribution of venous and arterial blood to the total blood volume in the brain is 3:1 
(Phelps et al., 1979). Because of its importance, there have been a number of studies  
that have attempted to measure the relative vascular distribution (Hueber et al., 2001; 
Kusaka et al., 2002; Watzman et al., 2000; Wiedeman, 1963). These studies compared NIRS 
tissue oxygenation measurements to oxygenation measurements from arterial and venous 
blood samples, and found results similar to the 3:1 ratio which was originally derived 
from cerebrovascular resistance measurements. In addition, it has been shown that the 
AVDO2 is relatively insensitive to errors in the assumed relative vascular contribution 
(Tichauer et al., 2010). 
5. Applications 
5.1 Detection of hypoxia-ischemia 
Recent clinical trials have demonstrated that the incidence of death and disability from 
hypoxic-ischemic brain injury in newborns can be significantly reduced by initiating 
treatment strategies – hypothermia for example – after birth and within a 6 h therapeutic 
window (Chaudhari & McGuire, 2008; Eicher et al., 2005a; Eicher et al., 2005b; Gluckman et 
al., 2005; Shankaran et al., 2005). Due to the brevity of the therapeutic window, early 
detection of injury and an early determination of those infants who are likely candidates for 
treatment are crucial (Gunn & Bennet, 2008). In this regard, traditional early indicators of 
brain injury – including Apgar scores, umbilical artery acidosis and fetal heart rate 
monitoring – suffer from poor specificity (Carter et al., 1998; Shankaran, 1998) and  
more specific indicators of injury, such as magnetic resonance imaging and spectroscopy, 
are insensitive or difficult to implement within the therapeutic window (Cady, 2001;  
Martin & Barkovich, 1995). To this point, the most promising and clinically-feasible 
monitoring technique for early indicator of hypoxia-ischemia (HI) after birth has been 
amplitude-integrated electroencephalography (aEEG) due to its ease of use, non-
invasiveness and high prognostic value as early as 3 h after birth (al Naqeeb et al., 1999; Toet 
et al., 1999). However, recent studies have questioned the sensitivity of aEEG to detect 
infants with milder injuries that could still benefit from treatment (Sarkar et al., 2008). 
Another potentially promising early indicator is reduction in CMRO2 since HI is believed to 
impair oxidative metabolism. 
To test the idea that NIRS-CMRO2 measurements can improve early detection of perinatal 
HI, measurements were acquired in newborn piglets (Tichauer et al., 2009) before and after 1 
h of reperfusion from HI – the duration of which was varied from piglet to piglet with a 
range of 3-24 min – under fentanyl/nitrous oxide anesthesia to mimic awake-like levels of 
cerebral metabolism. CMRO2 was found to be significantly depressed following the insult; 
mean CMRO2 was 2.61 ± 0.11 mlO2·min-1·100g-1 prior to the insult and 1.58 ± 0.09 mlO2·min-
1·100g-1 after 1 h of reperfusion, respectively. The NIRS-CMRO2 measurements were 
combined with aEEG and both measurements displayed statistically significant correlations 
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with duration of ischemia (p < 0.05; r = 0.71 and r = 0.89, respectively); however, only 
CMRO2 was sensitive to milder injuries (< 5 min). These evidences suggest that the NIRS-
CMRO2 technique has the potential to delineate different insult severities within 1 h of 
reperfusion from hypoxia-ischemia in a piglet model of perinatal HI. Since the technique can 
be applied at the bedside of the sick newborn, these results highlight its potential to improve 
diagnosis and to monitor treatment of hypoxic-ischemic encephalopathy within the 
therapeutic window. 
5.2 Focal brain injury 
Although the previous sections highlight the potential of using NIRS for early detection of 
brain injury in newborns, CBF and CMRO2 were only measured in a single brain volume as 
the NIRS instrument had only one detection channel. This limits the clinical applicability of 
the technique due to selective patterns of damage associated with major causes of neonatal 
brain injury, such as hypoxia-ischemia and intraventricular hemorrhage, and due to focal 
injury caused by ischemic stroke. To expand the detection capabilities of the NIRS apparatus 
to enable the measurements of regional CBF and CMRO2, a relatively simple multiplexing 
approach based on electronically controlled mechanical shutters has been proposed (Diop et 
al., 2009). The entire apparatus was housed in a cart (see Fig. 2) and could be moved to the 
bedside. The ability of this multi-detector NIRS instrument to detect regional CBF and 
CMRO2 abnormalities was tested in newborn piglets in which the vasoconstrictor 
Endothelin-1 (ET-1) was injected into the brain to cause a focal ischemic injury. Endothelin-1 
is an amino acid peptide that possesses prolonged and profound vasoconstrictive effects on 
cerebral blood vessels (Diop et al., 2009). For comparison, regional CBF was concurrently 
measured by CT perfusion. Due to limited space on the piglet head, only four detection 
channels were used in that study. A general reduction in CBF was observed across all 
detection channels with the magnitude decreasing farther from the site of ET-1 injection; a 
trend that was also observed in the CT perfusion images. An excellent agreement was also 
observed between CBF in the lesion site, as determined from the CT perfusion images, and 
CBF measured by the NIRS optode nearest to the lesion site (optode 1 in Fig. 4). The NIRS-
CMRO2 measurements showed that ET-1 injection did not cause a significant change in 
cerebral energy metabolism. This was expected as CMRO2 would be maintained, despite the 
reduction in CBF, by an increase in cerebral oxygen extraction. Although both NIRS and CT 
measured ~ 50% CBF reduction in the lesion region, this decrease was likely not sufficient to 
exhaust the compensatory effects of increased oxygen extraction. Typically, reductions in 
CMRO2 are not observed until CBF falls below 25 ml/100g/min. 
A limitation with this multi-channel NIRS apparatus is that it is not immune to partial-
volume errors which could result in an overestimation of CBF in focal lesions significantly 
smaller than the sensitivity volume of a source-detector unit. One approach to improving 
the spatial resolution would be to combine the multi-channel NIRS instrument with a 
discrete-wavelength continuous-wave system with multiple emission and detection 
optodes. Broadband NIRS could be used to determine the DPF and the steady-state Hb 
concentration needed to determine CMRO2. A discrete-wavelength imaging system could 
then be used to rapidly acquire dynamic ICG concentration data. The relative ICG data 
would be converted into absolute units using the DPF measurements. With such an 
approach, it may be possible to apply diffuse optical tomographic methods to further 
improve spatial resolution. 
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Fig. 4. Brain tissue ICG concentration curves obtained from detection optodes 1-4 before (a) 
and after (b) ET-1 injection. The reduction in the peak height of the ICG curve for optode 1 
after ET-1 injection reflects the reduction in CBF caused by the drug. Shown in the top right 
hand side of (a) is a cartoon of a piglet head showing the location of the 4 detection optodes 
(labelled 1-4) relative to the emission optode (labelled E). The emission-detector distance 
was 3 cm in all cases. The approximate position of the ET-1 injection site is represented by 
the orange mark between the emission optode and detection optode 1. 
6. Extra-cerebral signal contamination 
A major obstacle to NIRS clinical applications in adults is the presence of extra-cerebral 
tissues (scalp, skull and CSF) within the region interrogated by NIRS probes. For CBF 
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measurements, the measured ICG tissue concentration curve is comprised of both cerebral 
and non-cerebral components that are highly correlated. Using tracer kinetic models to 
recover CBF from a contaminated curve would result in an underestimation of CBF (Elliott 
et al., 2010; Gora et al., 2002; Owen-Reece et al., 1996). Solutions to overcoming this 
challenge have been proposed, including more advanced instrumentation as well as 
analytical approaches, with the main goal of increasing sensitivity to cerebral components. 
The presence of the extra-cerebral component in the measured signal makes the analytical 
problem underdetermined when using a single-channel continuous-wave configuration. To 
differentiate between signal arising from cerebral tissue and extracerebral contamination, 
more information about the light-tissue interaction is necessary. Several instrumentation 
approaches have emerged which provide additional information and include multi-distance 
(also known as spatially resolved), time-resolved and frequency-domain approaches. The 
additional data provided by these techniques facilitate the removal of extracerebral 
contamination by further constraining the system of equations which describe the change in 
light propagation due to the inflow of tracer. 
In depth-resolved NIRS, multiple detectors are used to simultaneously measure the optical 
signal at difference source-detector distances (Hongo et al., 1995; Pucci et al., 2010). This 
approach is based on the principle that the penetration depth of light increases with source-
detector distance. Therefore, the distance that light travels in each tissue type depends on both 
the geometry of the tissue layers as well as the source-detector distance. Measuring the NIR 
signal at a variety of source-detector distances for the same tissue structure provides a means 
of algebraically isolating information from the cerebral tissue. The main limitation of this 
approach is that the mean partial pathlength of light for a given source-detector distance is 
unknown and must therefore be determined using mathematical modeling, spectral 
information, anatomical priors, or a combination of these. Recently, a depth-resolved NIRS 
method that incorporated CT imaging data into a light propagation model  has been validated 
(Elliott et al., 2010). The determination of mean partial pathlengths using this approach 
allowed the removal of extracerebral contamination, and the recovered CBF values were in 
good agreement with independent measurements obtained with CT perfusion. Several other 
multi-distance techniques have been proposed, using time-resolved or frequency-domain 
methods to provide additional information (Liebert et al., 2004; Steinbrink et al., 2006). 
An effective way to isolate the deeper cerebral component of the signal is to collect 
information about individual photons, mainly the time required to travel from the source 
fibre, through the tissue, to the detector. This “time-of-flight” is a function of the optical 
properties of the tissue and the distribution of times-of-flight for a sample of photons can be 
considered as a unique signature of the tissue geometry and type. Similar to the depth-
resolved approach, photons with late arrival times are more likely to have propagated into 
cerebral tissue, but unlike in the case of depth-resolved NIRS, the relationship is not 
straight-forward. Instead, it is necessary to mathematically model the time-of-flight 
distribution (Kienle et al., 1998; Wang et al., 1995) to determine the optical properties of each 
medium. Changes in light attenuation recovered from this modeling can be converted to 
ICG concentration and deconvolved to yield CBF (Diop et al., 2010). 
In a similar way, when a frequency-modulated light signal is introduced into a tissue, the 
amplitude and phase components of the detected light depend on the tissue geometry and 
optical properties (Choi et al., 2004). In theory, the same time-of-flight information collected 
using time-resolved NIRS is contained in frequency-domain measurements. Since most 
analytical models employed in time-resolved analysis have solutions for the frequency 
domain as well, the two techniques are theoretically equivalent. 
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When using the methods discussed above, a certain amount of prior information is 
necessary to properly analyze the measured data. These priors include information 
regarding the geometry and type of tissue being interrogated, the optical properties of the 
tissues, and the placement and efficiency of the optical probes. Because the determination of 
these priors can often be challenging in a clinical environment, it is common to make a 
limited number of assumptions and simplifications. However, the number and quality of 
priors will usually affect the accuracy of the CBF measurement, making it necessary to 
carefully consider this trade-off. 
Perhaps the most important prior from a clinical perspective is anatomical information 
pertaining to the thickness and shape of the extracerebral layers, and must be incorporated 
into light propagation models. In the absence of this information, the head is treated either as a 
homogenous medium or as a simple two-layered structure with a top layer thickness based on 
the population average. Measurements of CBF determined using either of these two 
assumptions have been shown to be inaccurate under most clinical situations (Gora et al., 2002; 
Schytz et al., 2009). The accuracy of CBF measurements can be improved when the total 
thickness of the extra-cerebral layer, or preferably, the individual thicknesses of the scalp, skull 
and CSF layers are known (Elliott et al., 2010). Recent studies have also suggested that 
incorporating an imaging dataset from CT or MRI may further increase the accuracy of the 
measurements (Dehaes et al., 2011), but this has not yet been demonstrated experimentally. 
An alternative approach to the quantitative methods discussed above is to use semi-
quantitative comparisons to assess the relative change in blood flow as a function of time, or 
the relative difference in blood flow between different areas on the head (Liebert et al., 2005). 
While these techniques cannot quantify CBF, they may be effective in specific clinical 
applications even if no priors are available. Recently, Steinkeller et al. demonstrated the use of 
a semi-quantitative time-resolved NIRS technique to monitor cerebral perfusion in acute 
ischemic stroke patients (Steinkellner et al., 2010).  In this study, NIRS measurements were 
acquired over both hemispheres following the injection of tracer, and the time-to-peak, or time 
between first appearance of tracer and the peak concentration of tracer, was determined. In all 
patients, a larger time-to-peak was observed in the affected hemisphere, when compared to 
the normal hemisphere. 
7. Conclusion 
Near-infrared spectroscopy is already an accepted and widely used monitoring tool for the 
clinical management of patients since the ubiquitous pulse oximeter is in fact a NIRS 
instrument. Although NIRS instruments are in general relatively simple, analyzing the 
measured signal is not always straightforward. For this reason, interpreting NIRS data 
remains one of the major obstacles preventing its wide spread and routine clinical use. To 
overcome this challenge, better analytical tools need to be developed as well as stronger 
collaboration between researchers and clinicians. Another major problem with NIRS is the 
lack of widely accepted standards. Efforts are being made to solve this issue with multiple 
research groups working together to develop calibrated tissue mimicking phantoms. 
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